Join NexChange - the professional
network for the financial services
industry - and receive a free one-
year subscription to Forbes
Biosensors receives takeover proposal from CITIC PE
After jilting Biosensors at the takeover altar, CITIC Private Equity is back to make amends, and then some.
In a recent filing with the Singapore Exchange, Biosensors’ board of directors said they have received a takeover offer from CITIC Private Equity for an undisclosed amount, adding that “discussions are on-going,” and that “there is no certainty or assurance that these discussions will result in any transaction.”
You can understand why they’re a little skeptical about it. Biosensors, a Singapore-listed, China-based medical device manufacturer, was originally propositioned by CITIC PE back in 2014, but according to another filing on the SGX, the private equity firm called off its plans and just wanted to be friends instead:
“[T]he Board wishes to announce that CITIC Private Equity Funds Management Co., Ltd. (“CITIC PE”) has informed the Company that it has decided not to proceed with any take-over transactions involving the shares in the Company at this point of time. CITIC PE remains committed to cooperating with the Company and its management with a view to ensuring the Company’s continued success and to enhancing the value of CITIC PE’s investment.”
Biosensors has called for a trading halt on its shares. We wish them all the best.
Photo: Christina Alexanderson